Prevail Therapeutics
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Prevail Therapeutics
RECRUITINGPhase 1NCT06565195
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
The purpose of this study is to evaluate the safety, tolerability, and PK/PD of LY3962681 in healthy volunteers and patients with Parkinson's disease. The study will be comprised...
Sponsor: Prevail TherapeuticsEnrolling: 1084 locations
Parkinson's Disease
RECRUITINGPhase 1 / Phase 2NCT05487599
A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)
Study J3Z-MC-OJAE is a Phase 1/2, multicenter, open-label, dose-finding study of LY3884961 evaluating the safety and tolerability in adults with peripheral manifestations of GD....
Sponsor: Prevail TherapeuticsEnrolling: 158 locations
Gaucher DiseaseGaucher Disease, Type 1